Wells Fargo
COYA icon

Wells Fargo’s Coya Therapeutics COYA Stock Holding History

Wells Fargo’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.97K Buy
+500
New +$2.34K ﹤0.01% 6252
2024
Q2 		– Sell
-100
Closed -$992 – 7002
2024
Q1 		$992 Buy
100
+35
+54% +$274 ﹤0.01% 6153
2023
Q4 		$482 Buy
65
+4
+7% +$22 ﹤0.01% 6393
2023
Q3 		$234 Buy
61
+38
+165% +$151 ﹤0.01% 6547
2023
Q2 		$94 Buy
23
+1
+5% +$5 ﹤0.01% 6881
2023
Q1 		$87 Buy
+22
New +$96 ﹤0.01% 6964

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Wells Fargo's COYA Position: Q1 2026 in Review

Wells Fargo opened a new position in Coya Therapeutics (COYA) in Q1 2026: 500 shares worth $1.97K. The stake represents ﹤0.01% of the portfolio and ranks #6252 among its holdings. This is a return to the name: Wells Fargo previously reported a position in COYA as recently as Q1 2024.

Wells Fargo first reported a position in COYA in Q1 2023 and has held it in 6 quarters since. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Wells Fargo held 500 shares of Coya Therapeutics worth $1.97K as of Q1 2026.
  • Coya Therapeutics was a new Wells Fargo position in Q1 2026.
  • Coya Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6252 holding.
  • Wells Fargo first reported a position in Coya Therapeutics in Q1 2023 and has held it in 6 quarters since.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.